CE Holdings Co., Ltd. (4320.T)
JPY 550.0
(0.18%)
JPY 550.0
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.63 Billion | 13.7 Billion | 12.28 Billion | 10.6 Billion | 11.65 Billion | 9.04 Billion |
| Cost of Revenue | 9.94 Billion | 10.54 Billion | 9.63 Billion | 8.58 Billion | 9.4 Billion | 7.31 Billion |
| Gross Profit | 3.69 Billion | 3.15 Billion | 2.64 Billion | 2.01 Billion | 2.25 Billion | 1.72 Billion |
| Operating Expenses | 2.43 Billion | 2.12 Billion | 1.76 Billion | 1.46 Billion | 1.28 Billion | 1.2 Billion |
| Selling, General and Administrative Expenses | 402.42 Million | 291.04 Million | 208.91 Million | 184.71 Million | 166.09 Million | 172.93 Million |
| Research and Development Expenses | 137.73 Million | 178.39 Million | 147.15 Million | 45.91 Million | 14.56 Million | 14.77 Million |
| Other Expenses | 1.89 Billion | 1.65 Billion | 1.41 Billion | 1.23 Billion | 1.1 Billion | 15.3 Million |
| Cost and Expenses | 12.37 Billion | 12.67 Billion | 11.4 Billion | 10.05 Billion | 10.68 Billion | 8.52 Billion |
| Operating Income | 1.28 Billion | 1.03 Billion | 879.06 Million | 547.07 Million | 961.69 Million | 526.28 Million |
| Interest Expense | 6.95 Million | 7.94 Million | 8.93 Million | 11.44 Million | 2.52 Million | 3.42 Million |
| Income Tax Expense | 489.16 Million | 383.83 Million | 278.92 Million | 187.25 Million | 353.04 Million | 193.23 Million |
| Earnings before Tax | 1.26 Billion | 1.06 Billion | 1 Billion | 360.73 Million | 984.38 Million | 537.24 Million |
| Net Income | 687.53 Million | 588 Million | 632.92 Million | 173.47 Million | 531.79 Million | 290.93 Million |
| Earnings Per Share Basic | 45.91 | 39.13 | 42.34 | 11.57 | 35.26 | 20.00 |
| Earnings Per Share Diluted | 45.91 | 39.13 | 42.34 | 11.56 | 35.13 | 19.47 |
| Weighted Average Shares Outstanding | 14.97 Million | 15.02 Million | 14.94 Million | 14.99 Million | 15.08 Million | 14.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.97 Million | 15.02 Million | 14.94 Million | 15 Million | 15.13 Million | 14.94 Million |
| Gross Margin | 0.27 | 0.23 | 0.22 | 0.19 | 0.19 | 0.19 |
| EBIT Margin | 0.13 | 0.10 | 0.10 | 0.08 | 0.10 | 0.08 |
| Profit Margin | 0.05 | 0.04 | 0.05 | 0.02 | 0.05 | 0.03 |
| EBITDA | 1.7 Billion | 1.44 Billion | 1.35 Billion | 732.21 Million | 1.19 Billion | 706.76 Million |
| Earnings Before Tax Margin | 0.09 | 0.08 | 0.07 | 0.05 | 0.08 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.84 Billion | 4.89 Billion | 3.17 Billion | 13.63 Billion | 3.88 Billion | 2.4 Billion |
| Cost of Revenue | 2.33 Billion | 3.8 Billion | 2.39 Billion | 9.94 Billion | 2.79 Billion | 1.77 Billion |
| Gross Profit | 515.67 Million | 1.09 Billion | 772.79 Million | 3.69 Billion | 1.09 Billion | 633.64 Million |
| Operating Expenses | 547.84 Million | 541.46 Million | 585.57 Million | 2.43 Billion | 725.15 Million | 587.53 Million |
| Selling, General and Administrative Expenses | 549.42 Million | 539.46 Million | 563.67 Million | - | 692.83 Million | 556.94 Million |
| Research and Development Expenses | - | 2 Million | 11 Million | - | 20.73 Million | 19 Million |
| Other Expenses | 1.58 Million | 1.41 Million | 6.36 Million | 6.83 Million | -702 Thousand | 4.17 Million |
| Cost and Expenses | 2.88 Billion | 4.34 Billion | 2.98 Billion | 12.37 Billion | 3.51 Billion | 2.35 Billion |
| Operating Income | -32.16 Million | 554.26 Million | 187.21 Million | 1.25 Billion | 369.21 Million | 46.11 Million |
| Interest Expense | 3.59 Million | 3.73 Million | 1.43 Million | 6.95 Million | 1.72 Million | 1.59 Million |
| Income Tax Expense | 83.03 Million | 193.31 Million | 146.3 Million | 489.16 Million | 118.46 Million | 44.92 Million |
| Earnings before Tax | -460.51 Million | 551.61 Million | 192.65 Million | 1.26 Billion | 343.09 Million | 57.83 Million |
| Net Income | -539.73 Million | 326.64 Million | 45.07 Million | 687.53 Million | 166.87 Million | 25.8 Million |
| Earnings Per Share Basic | -35.93 | 21.68 | 3.01 | - | 11.16 | 1.73 |
| Earnings Per Share Diluted | -35.93 | 21.68 | 3.01 | - | 11.16 | 1.73 |
| Weighted Average Shares Outstanding | 15.02 Million | 15.06 Million | 14.95 Million | 14.97 Million | 14.94 Million | 14.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.02 Million | 15.06 Million | 14.95 Million | 14.97 Million | 14.94 Million | 14.94 Million |
| Gross Margin | 0.18 | 0.22 | 0.24 | 0.27 | 0.28 | 0.26 |
| EBIT Margin | 0.11 | 0.14 | 0.06 | - | 0.09 | 0.02 |
| Profit Margin | -0.19 | 0.07 | 0.01 | 0.05 | 0.04 | 0.01 |
| EBITDA | 304 Million | 677.35 Million | 193.96 Million | - | 366.17 Million | 52.69 Million |
| Earnings Before Tax Margin | -0.01 | 0.11 | 0.06 | 0.09 | 0.10 | 0.02 |
PRIMESECU
AUROPHARMA
3075
060280
VEOEY
JASH